Abstract
Ocular inflammation may affect all eye layers: conjunctiva, sclera, uvea, and orbital tissues. The main eye involvement requiring a systemic treatment is uveitis, which represents a heterogeneous group of rare diseases, most of which are sight-threatening. In around 40% of uveitis cases an underlying systemic disease, often of autoimmune origin, can be identified. In autoimmune diseases with intraocular inflammation (IOI), uveitis may be the first clinical manifestation and may represent the most severe sign. Studies in animal models, especially in experimental autoimmune uveitis (EAU), offer the opportunity to investigate the pathogenicity of these disorders. The conventional treatment of IOI includes corticosteroids and immunosuppressive agents, which are efficient in around one-half of the patients; however, their effectiveness is also limited by their iatrogenicity. The effects of intravenous immunoglobulin (IVIg) on ocular inflammation have been investigated in a wide spectrum of autoimmune/systemic diseases. Most publications are case series or open trials. They show favorable results in a subset of indications including mainly ocular cicatricial pemphigoid, Vogt-Koyanagi-Harada syndrome, or birdshot disease. Efficacy results are more debated in other conditions, such as inflammatory demyelinating optic neuritis. In other diseases with IOI (Wegener disease, Behcet’s disease, inflammatory myositis), only case reports are available, suggesting that IVIg may be of some interest.
These observations support the need for controlled trials to demonstrate the efficacy of IVIg and assess their potential steroid-sparing effect.
Similar content being viewed by others
References
Nussenblatt, R. B. (2002), Intern Rev Immunol 21, 273–289.
Blakeslee, A. (1986), Sight Saving Review 5, 16.
US Department of Health and Human Services: Vision Research: A National Plan: Report of the Retinal and Choroidal Diseases Panel. 1983–1987, NIH Publication, No. 83-2471, pp. 33.
Smit, R. L., Baarsma, G. S., and De Vries, J. (1993), Int Ophthalmol 17, 71–76.
Bodaghi, B., Cassoux, N., Wechsler, B., et al. (2001), Medicine 80, 263–270.
Wacker, W. B. and Lipton, M. M. (1965), Nature 206, 253–254.
Gery, I., Mochizuki, M., and Nussenblatt, R. B. (1986), Prog. Retinal Res 5, 75.
Whitcup, S. M. and Nussenblatt, R. B. (1993), Ann NY Acad Sci 696, 307–318.
Shinohara, T. et al. (1992), Prog Retinal Res 8, 51.
Chan, C. C., Mochizuki, M., Nussenblatt, R. B., et al. (1985), Cell Immunol Immunopathol 35, 103–110.
Chan, C. C., Mochizuki, M., Palestine, A. G., et al. (1985), Cell Immunol 96, 430–434.
Saoudi, A., Hurez, V., de Kozak, Y., et al. (1993), Int Immunol 5, 1559–1567.
Hurez, V., Kazatchkine, M. D., Vassilev, T., et al. (1997), Blood 90, 4004–4013.
Obrador, E., Peinado, E., de Kozak, Y., et al. (1999), Ophthalmic Res 31, 59–67.
Nussenblatt, R. B., Palestine, A. G., Chan, C. C., et al. (1991), Am J Ophthalmol 112, 138–146.
Sunakawa, M. (1989), Metab Pediatr Syst Ophthalmol 12, 93–95.
Rosenbaum, J. T., George, R. K., and Gordon, C. (1999), Am J Ophthalmol 127, 545–549.
Ryan, S. J. and Maumenee, A. E. (1980), Am J Ophthalmol 89, 31–45.
LeHoang, P., Ozdemir, N., Benhamou, A., et al. (1992), Am J Ophthalmol 113, 33–35.
Rothova, A., Berendschot, T. T., Probst, K., et al. 92004), Ophthalmology 111, 954–959.
LeHoang, P., Cassoux, N., George, F., et al. (2000), Ocul Immunol Inflamm 8, 49–57.
Karmochkine, M., Kazatchkine, M. D., and Lehoang, P. (1998), Ann Intern Med 129, 1078–1079.
Bartley, G. B., Fatourechi, V., Kadrmas, E. F., et al. (1996), Am J Ophthalmol 121, 284–290.
Perros, P., Crombie, A. L., and Kendall-Taylor, P. (1995), Clin Endocrinol (Oxf) 42, 45–50.
Prummel, M. F., Mourits, M. P., Blank, L., et al. (1993), Lancet 342, 949–954.
Antonelli, A., Saracino, A., Alberti, B., et al. (1992), Acta Endocrinol (Copenh) 126, 13–23.
Kahaly, G., Pitz, S., Muller-Forell, W., et al. (1996), Clin Exp Immunol 106, 197–202.
Seppel, T., Schlaghecke, R., Becker, A., et al. (1996), Clin Exp Rheumatol 14, S109-S114.
Baschieri, L., Antonelli, A., Nardi, S., et al. (1997), Thyroid 7, 579–585.
Dabelsteen, E., Ullman, S., Thomsen, K., et al. (1974), Acta Derm Venereol 54, 189–192.
Foster, C. S. and Sainz de la Maza, M. (2004), Curr Opin Allergy Clin Immunol 4, 435–439.
Chan, R.Y., Bhol, K., Tesavibul, N. et al. (1999), Invest Ophthalmol Vis Sci 40, 2283–2290.
Razzaque, M. S., Foster, C. S., and Ahmed, A. R. (2002), Invest Ophthalmol Vis Sci 43, 2977–2983.
Razzaque, M. S., Foster, C. S., and Ahmed, A. R. (2003), Invest Ophthalmol Vis Sci 44, 1616–1621.
Razzaque, M. S., Ahmed, B. S., Foster, C. S., et al. (2003), Invest Ophthalmol Vis Sci 43, 3417–3423.
Nakamura, T., Nishida, K., Dota, A., et al. (2002), Invest Ophthalmol Vis Sci 43, 1702–1707.
Neuman, R., Taber, J., and Foster, C. S. (1991), Ophthalmology 98, 858–862.
Urcelay, M. L., McQueen, A., and Douglas, W. S. (1997), Br J Dermatol 137, 477–478.
Sami, N., Bhol, K. C., and Razzaque Ahmed, A. (2002), Clin Immunol 102, 59–67.
Sami, N., Letko, E., Androudi, S., et al. (2004), Ophthalmology 111, 1380–1382.
Letko, E., Miserocchi, E., Daoud, Y. J., et al. (2004), Clin Immunol 111, 303–310.
Letko, E., Bhol, K., Foster, S. C., et al. (2000), Cur Eye Res 21, 646–654.
Kumari, S., Bhol, K. C., Rehman, F., et al. (2001), Cytokine 14, 218–224.
Kalina, P. H., Lie, J. T., Campbell, R. J., et al. (1992), Ophthalmology 99, 120–124.
Jayne, D. R., Davies, M. J., Fox, C. J., et al. (1991), Lancet 337, 1137–1139.
Blum, M., Andrassy, K., Adler, D., et al. (1997), Graefe’s Arch Clin Exp Ophthalmol 235, 599–602.
Helveston, W. R. and Gilmore, R. (1996), Neurology 46, 584–585.
Gonzales-Delgado, M., Gonzalez, C., Blazquez, J. I., et al. (2004), Neurologia 19, 401–403.
Kokotis, P., Theodossiadis, P., Bouros, C., et al. (2005), J Rheumatol 32, 379–381.
Shambal, S., Lindner, A., and Zierz, S. (1998), Muscle Nerve 21, 1359–1360.
Beck, R. W., Cleary, P. A., Anderson, M. M. Jr., et al. (1992), N Engl J Med 326, 581–588.
Rodriguez, M. and Lennon, V. A. (1990), Ann Neurol 27, 12–17.
Van Engelen, B. G., Hommes, O. R., Pinckers, A., et al. (1992), Ann Neurology 32(6), 834–835.
Curro Dossi, B., Amadori, A., Cirafisi, C., et al. (1998), Ital J Neurol Sci 19, 45–48.
Frohman, L. P., Cook, S. D., and Bielory, L. (1991), J Clin Neuroophthalmol 11, 241–245.
Noseworthy, J. H., O’Brien, P. C., Petterson, T. M., et al. (2001), Neurology 56, 1514–1522.
Gajdos, P., Chevret, S., Clair, B., et al. (1997), Ann Neurol 41, 789–796.
Guy, J. and Aptsiauri, N. (1999), Arch Ophthalmol 117, 471–477.
Keltner, J. L., Thirkill, C. E., and Yip, P. T. (2001), J Neuroophthalmol 21, 173–187.
Seider, N., Beiran, I., Scharf, J., et al. (2001), Br J Ophthalmol 85, 1287–1288.
Drosos, A. A., Petris, C. A., Petroutsos, G. M., et al. (1989), Clin Rheumatol 8, 49–53.
Aharon, A., Zandman-Goddardd, G., and Shoenfeld, Y. (1994), Clin Rheumatol 13, 631–635.
Callaway, J. K. and Bennett, C. J. (2002), Intern Med J 32, 421–422.
Bachmeyer, C., Turc, Y., Curan, D., et al. (2000), Am J Ophthalmol 129, 101–102.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tellier, Z. Intravenous immunoglobulin in eye involvement. Clinic Rev Allerg Immunol 29, 295–306 (2005). https://doi.org/10.1385/CRIAI:29:3:295
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:29:3:295